Overview on the treatment of Lyme disease in pregnancy

G Ital Dermatol Venereol. 2020 Apr;155(2):220-222. doi: 10.23736/S0392-0488.19.06396-X. Epub 2019 Jun 17.

Abstract

Lyme disease is a tick-borne illness, which is typically caused by Borrelia Burgdoferi. Over time, a typical Borreliosis skin reaction takes shape, i.e. the formation of an annular erythema that tends to expand centrifugally with erythematous edges whose diameter can reach up to 20 cm. The symptoms of Lyme disease are not only cutaneous but there may be a systemic involvement. Obviously, this disease can also affect pregnant women and for this reason this review aims to summarize the main ways of treatment to avoid worsening of the clinical condition in the mother and an eventual, albeit rare, involvement of the fetus.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Female
  • Humans
  • Lyme Disease / drug therapy*
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*

Substances

  • Anti-Bacterial Agents